TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors
Stopped early · Phase 2
Conditions studied: Non-Malignant Hematologic Disorders
In brief
The purpose of this study is to find out if removing a specific type of white blood cell (called alpha beta T-cell) that help make up the transplant donor's stem cells can improve results of blood stem cell transplant for the participant's disease.
Key facts
- Study ID
- NCT03615144
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 1
- Starts
- 2018-07-23
- Expected to finish
- 2020-11-13
- Last updated by the study team
- 2021-03-24
Who can join
Age: 1 and older, up to 69. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Memorial SloanKettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.